Specialty Research and Innovation
-
Featured
Favipiravir to Treat COVID-19: Q&A with Boris Juelg, MD, PhD
Boris Juelg, MD, PhD, an attending physician in the Division of Infectious Diseases at Massachusetts General Hospital and an assistant professor at Harvard Medical School, explains what is currently known about the drug favipiravir and why he is excited about its potential to treat COVID-19 patients.
-
Featured
Mass General Launching Randomized, Controlled Trial of Tocilizumab for COVID-19
Tocilizumab, a monoclonal antibody that blocks IL-6 already approved in the U.S., might be effective against COVID-19, researchers from Massachusetts General Hospital believe.
-
Featured
Using Chloroquine to Treat COVID-19: Q&A with Raghu Chivukula, MD, PhD
Raghu Chivukula, MD, PhD, a physician-scientist in the Division of Pulmonary and Critical Care Medicine at Massachusetts General Hospital, explains what is currently known about chloroquine and its use to treat COVID-19 patients.
-
Program Co-Chair, Keith Flaherty, MD, Recaps Key Highlights From AACR 2024
Keith Flaherty, MD, director of clinical research at Mass General Cancer Center and program co-chair of this year's AACR Annual Meeting, shares key highlights and favorite talks from the conference.
-
Pathways Case Report: Blood Finds a Way
A 30-year-old woman presented to the hospital and was ultimately discovered to have extensive veno-venous collaterals between anterior, systemic, and chest wall veins connecting directly to their right superior pulmonary veins and left atrium. The Pathways Consult Service at Massachusetts General Hospital investigated.
-
Pathways Case Record: An Immunocompetent Patient With Disseminated CMV
A 49-year-old male presented to Massachusetts General Hospital, found to have new heart failure with a reduced ejection fraction and pericardial effusion. Testing revealed elevated cytomegalovirus (CMV) viral load, so the Pathways Service investigated how a previously immunocompetent patient developed CMV reactivation.
Research and Innovation Contributors
-
Andrew T. Chan, MD, MPH
Daniel K. Podolsky Professor of Medicine, Harvard Medical School, Director for Cancer Epidemiology, Mass General Cancer Center, Chief, Clinical and Translational Epidemiology Unit, Department of Medicine
Recent Article
PPI, H2RA Use by Older Adults Not Associated With Dementia or Cognitive Impairment
-
Benjamin David Medoff, MD
Principal Investigator, Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Associate Professor of Medicine, Harvard Medical School
Recent Article
Targeted Nanoparticles Permit Cell-specific Drug Delivery in Pulmonary Fibrosis
-
Boris D. Juelg, MD, PhD
Attending Physician, Division of Infectious Diseases, Massachusetts General Hospital, Assistant Professor, Harvard Medical School
Recent Article
Favipiravir to Treat COVID-19: Q&A with Boris Juelg, MD, PhD
-
Bryan Hayes, PharmD, DABAT, FAACT, FASHP
Assistant Professor of Emergency Medicine, Harvard Medical School, Senior Attending Pharmacist, Emergency Medicine and Toxicology, Massachusetts General Hospital
Recent Article
The Use of NSAIDs in COVID-19 Patients: Q&A with Bryan D. Hayes, PharmD -
Charles Corey Hardin, MD, PhD
Physician, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Assistant Professor of Medicine, Harvard Medical School, Physician Investigator, Pulmonary, Mass General Research Institute
Recent Article
Persistent Dyspnea After COVID-19 May Have Another Cause
-
David M. Dudzinski, MD, JD
Intensive Care Cardiologist, Massachusetts General Hospital, Director, Cardiac Intensive Care Unit, Associate Editor, Case Records of the MGH
Recent Article
Standardizing Critical Care Cardiology Training
-
Elizabeth Louise Hohmann, MD
Staff Physician, Infectious Diseases Division, Massachusetts General Hospital, Chair and Physician Director, Partners Human Research Committees
Recent Article
Encapsulated Fecal Microbiota Transplantation Alters Gut Microbiome in Adults with Obesity -
Gregory D. Lewis, MD
Jeffrey and Mary Ellen Jay Chair and Section Head of Heart Failure, Medical Director of Heart Transplantation
Recent Article
Higher Peak Systolic BP on Exercise Testing May Not Indicate Adverse Vascular Function
-
Guillermo (Gary) Tearney, MD, PhD
Professor of Pathology, Harvard Medical School, Pathologist/Physicist, Massachusetts General Hospital, Faculty, Wellman Center for Photomedicine
Recent Article
MGH Research Scholars Respond to COVID-19 -
Lorenzo Berra, MD
Medical Director, Respiratory Care, Massachusetts General Hospital
Recent Article
Inhaled Nitric Oxide Improves Oxygenation in Pregnant Patients With COVID-19 Pneumonia
-
Louise C. Ivers, MD
Interim Director of the Division of Infectious Diseases, Executive Director of the Mass General Center for Global Health
-
Raghu Chivukula, MD, PhD
Physician-Scientist, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital
Recent Article
Review: Evidence-Based Management of the Critically Ill Adult with COVID-19
-
Tomas G. Neilan, MD, MPH
Director, Cardio-Oncology Program, Massachusetts General Hospital, Co-Director, Cardiac MR PET CT Program
Recent Article
T1 Value on Cardiac MRI Diagnoses Myocarditis Associated with Checkpoint Inhibitors
-
Vicki Jackson, MD
Chief, Division of Palliative Care & Geriatric Medicine, Massachusetts General Hospital, Professor of Medicine, Harvard Medical School
Recent Article
Group Report: Psychological Aspects of Palliative Care
